Effect of cotrimoxazole on causes of death, hospital admissions and antibiotic use in HIV-infected children.

Effect of cotrimoxazole on causes of death, hospital admissions and antibiotic use in HIV-infected children.

BACKGROUND: Cotrimoxazole prophylaxis reduces morbidity and mortality in HIV-1-infected children, but mechanisms for these benefits are unclear. METHODS: CHAP was a randomized trial comparing cotrimoxazole prophylaxis with placebo in HIV-infected children in Zambia where background bacterial resista...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Mulenga, V, Ford, D, Walker, A, Mwenya, D, Mwansa, J, Sinyinza, F, Lishimpi, K, Nunn, A, Gillespie, S, Zumla, A, Chintu, C, Gibb, D
التنسيق:	Journal article
اللغة:	English
منشور في:	2007

مواد مشابهة

The impact of daily cotrimoxazole prophylaxis and antiretroviral therapy on mortality and hospital admissions in HIV-infected Zambian children.
حسب: Walker, A, وآخرون
منشور في: (2007)

Impact of cotrimoxazole on carriage and antibiotic resistance of Streptococcus pneumoniae and Haemophilus influenzae in HIV-infected children in Zambia.
حسب: Mwenya, D, وآخرون
منشور في: (2010)

Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP Trial.
حسب: Walker, A, وآخرون
منشور في: (2006)

Adherence to both cotrimoxazole and placebo is associated with improved survival among HIV-infected Zambian children.
حسب: Walker, A, وآخرون
منشور في: (2009)

Improved growth and anemia in HIV-infected African children taking cotrimoxazole prophylaxis.
حسب: Prendergast, A, وآخرون
منشور في: (2011)

Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial.
حسب: Chintu, C, وآخرون
منشور في: (2004)

The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in Zambia.
حسب: Ryan, M, وآخرون
منشور في: (2008)

Reduced bacterial skin infections in HIV-infected African children randomized to long-term cotrimoxazole prophylaxis
حسب: Prendergast, A, وآخرون
منشور في: (2016)

Cotrimoxazole-Induced Hypoglycemia in an HIV-Infected Patient
حسب: Christine A Hughes, وآخرون
منشور في: (2001-01-01)

Co-trimoxazole prophylaxis in African children with HIV-1 - Reply
حسب: Gibb, D, وآخرون
منشور في: (2005)

Cotrimoxazole prophylaxis for infants exposed to HIV infection
حسب: Stephen M. Graham

Cotrimoxazole prophylaxis for infants exposed to HIV infection
حسب: Stephen M. Graham
منشور في: (2004-04-01)

Cotrimoxazole reduces systemic inflammation in HIV infection by altering the gut microbiome and immune activation
حسب: Bourke, CD, وآخرون
منشور في: (2019)

Cotrimoxazole prophylaxis and tuberculosis risk among people living with HIV.
حسب: Christopher J Hoffmann, وآخرون
منشور في: (2014-01-01)

Linking HIV-infected TB patients to cotrimoxazole prophylaxis and antiretroviral treatment in India.
حسب: Neeraj Raizada, وآخرون
منشور في: (2009-06-01)

Reconsidering empirical cotrimoxazole prophylaxis for infants exposed to HIV infection
حسب: Gill Christopher J., وآخرون
منشور في: (2004-01-01)

Is nevirapine dose-escalation appropriate in young, African, HIV-infected children?
حسب: Fillekes, Q, وآخرون
منشور في: (2013)

Identification of Pneumocystis carinii DNA by polymerase chain reaction in necropsy lung samples from children dying of respiratory tract illnesses.
حسب: Kasolo, F, وآخرون
منشور في: (2002)

Identification of Pneumocystis carinii DNA in oropharyngeal mouth washes from AIDS children dying of respiratory illnesses.
حسب: Lishimpi, K, وآخرون
منشور في: (2002)

Pharmacokinetics of nevirapine in HIV-infected children under 3 years on rifampicin-based antituberculosis treatment.
حسب: Oudijk, J, وآخرون
منشور في: (2012)

Estimating the impact of alternative programmatic cotrimoxazole strategies on mortality among children born to mothers with HIV: A modelling study.
حسب: Shrey Mathur, وآخرون
منشور في: (2024-02-01)

Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects
حسب: Haberer, J, وآخرون
منشور في: (2011)

Operational research in malawi: making a difference with cotrimoxazole preventive therapy in patients with tuberculosis and HIV
حسب: Schouten Erik J, وآخرون
منشور في: (2011-07-01)

Cotrimoxazole prophylaxis and risk of severe anemia or severe neutropenia in HAART-exposed, HIV-uninfected infants.
حسب: Scott Dryden-Peterson, وآخرون
منشور في: (2013-01-01)

Time for new recommendations on cotrimoxazole prophylaxis for HIV-exposed infants in developing countries?
حسب: Anna Coutsoudis, وآخرون

Time for new recommendations on cotrimoxazole prophylaxis for HIV-exposed infants in developing countries?
حسب: Anna Coutsoudis, وآخرون
منشور في: (2010-12-01)

Factors associated with coverage of cotrimoxazole prophylaxis in HIV-exposed children in South Africa.
حسب: Dhayendre Moodley, وآخرون
منشور في: (2013-01-01)

Identification of the phenotypic, genotypic and fitness correlates of non-B subtype HIV-1 NRTI resistance through longitudinal analysis of children with virological failure in the developing world
حسب: Mbisa, J, وآخرون
منشور في: (2010)

Dynamics of emergence and linkage of HIV reverse transcriptase Q151M MDR complex in children within first-line antiretroviral rollout uncovered by single-genome sequencing
حسب: Mbisa, J, وآخرون
منشور في: (2009)

Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tablets.
حسب: Fillekes, Q, وآخرون
منشور في: (2012)

Dosing regimens of cotrimoxazole (trimethoprim-sulfamethoxazole) for melioidosis.
حسب: Cheng, A, وآخرون
منشور في: (2009)

Limited sampling models to predict the pharmacokinetics of nevirapine, stavudine, and lamivudine in HIV-infected children treated with pediatric fixed-dose combination tablets.
حسب: Burger, D, وآخرون
منشور في: (2010)

A mortality review of tuberculosis and HIV co-infected patients in Mahalapye, Botswana: Does cotrimoxazole preventive therapy and/or antiretroviral therapy protect against death?
حسب: Stephane Tshitenge, وآخرون
منشور في: (2018-11-01)

Drug resistance in human immunodeficiency virus type-1 infected Zambian children using adult fixed dose combination stavudine, lamivudine, and nevirapine.
حسب: Gupta, R, وآخرون
منشور في: (2010)

Successful Treatment of Actinomycetoma with Combination of Cotrimoxazole and Tetracycline
حسب: Verdy Verdy, وآخرون
منشور في: (2016-03-01)

Necrólisis tóxica epidérmica inducida por cotrimoxazol
حسب: Rolando Rodríguez Hernández, وآخرون

Comparison between itraconazole and cotrimoxazole in the treatment of paracoccidiodomycosis.
حسب: Ricardo de Souza Cavalcante, وآخرون
منشور في: (2014-04-01)

Discontinuing cotrimoxazole preventive therapy in HIV-infected adults who are stable on antiretroviral treatment in Uganda (COSTOP): A randomised placebo controlled trial.
حسب: Zacchaeus Anywaine, وآخرون
منشور في: (2018-01-01)

Impact of Anti-Retroviral Treatment and Cotrimoxazole Prophylaxis on Helminth Infections in HIV-Infected Patients in Lambaréné, Gabon.
حسب: Saskia Janssen, وآخرون
منشور في: (2015-05-01)

National policy development for cotrimoxazole prophylaxis in Malawi, Uganda and Zambia: the relationship between Context, Evidence and Links
حسب: Chishinga Nathaniel, وآخرون
منشور في: (2011-06-01)